Alliance for a Stronger FDA

The Alliance for a Stronger FDA is hosting Center Directors and other FDA senior leaders to discuss their portion of the the president’s Fiscal Year 2025 budget request (documentsanalysis).   

Our food-focused lineup includes Human Foods Program Deputy Commission Jim Jones, Center for Veterinary Medicine Director Tracey

Continue Reading Alliance for a Stronger FDA to discuss funding request in webinar series

The reorganization of the Food and Drug Administration’s human foods programs was urgently needed and a long-time coming. The full plan still needs to go through review by Office of Management and Budget and then Congress. 

Fortunately, the Department of Health and Human Services and FDA have authority to implement

Continue Reading Webinar on FDA’s food chemical safety initiatives to feature Deputy Commissioner Jim Jones

The FDA’s largest reorganization in history, involving about 8,000 employees, is far more than just “moving some boxes around.”  The proposed changes and updates to an FDA-wide reorganization plan have been out for external reviews and clearances since Dec. 13, 2023, and implementation should occur sometime during 2024.

A “Unified

Continue Reading FDA reorganization is out for review, but impact later in 2024 could be huge

Food safety was called out this year as the step-child of the Food and Drug Administration. And the FDA Commissioner who called for an outside review by Reagan-Udall Foundation did not seem to doubt there are leadership and organizational problems. The Foundation’s report also seemed to lay everything on the

Continue Reading Congress giving FDA $41 million more for its troubled food safety activities

The Alliance for a Stronger FDA — a stakeholder organization with 150+ groups and individuals devoted to advocating for increased appropriations for the FDA and educating policymakers and the public about the FDA’s mission and responsibilities — has said the following about FDA funding for the federal fiscal year 2022:
Continue Reading Alliance for a Stronger FDA weighs in on FY22 Appropriations Bil